|
Presentations
Details of speakers along with abstracts and biographies will be posted here as we receive them
Speakers listed alphabetically:
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
| Key: |
 |
= Listen to speech online |
 |
= View powerpoint presentation online |
Drugs and the new administration
Martin Barnes, Chief Executive, Drugscope
Twitter ye not
and
Do you share? - Looking beyond the 'sharing' question
Nigel Brunsdon, Trainer / Blogger, Injecting Advice Ltd, Derby
TOP
More than anabolic steroids
Martin Chandler, Inter Agency Drug Misuse Database Manager, Centre for Public Health, Liverpool John Moores University
What do we know about the adulteration of illicit drugs?
Claire Cole, Honorary Lecturer, Centre for Public Health, Liverpool John Moores University
Global state of harm reduction 2010
Catherine Cook, Senior Analyst: Public Health, Research and Policy, International Harm Reduction Association (IHRA), London
Getting drug dealers involved in harm reduction
Ross Coomber, Professor of Sociology and Director, Drug and Alcohol Research Unit, School of Social Science and Social Work, University of Plymouth
The Welsh BBV hepatitis action plan
Noel Craine, Research Scientist, Public Health Wales
TOP
Neck injecting risks and harm reduction
and
Promoting transition from injecting to smoking
and
Promoting transition to smoking in the UK: panel discussion
Jon Derricott, Exchange Supplies
Twitter ye not?
Allison Downing, Trainer / Podcaster, Simply Syndicated
TOP
Understanding drug using networks: The seeds of a formal peer education programme
Richard Foley, Blood Borne Virus Prevention Worker, Harm Reduction Team (NHS Lothian), Edinburgh
Needle size - influencing choice in needle exchange
Kevin Flemen, Independent Trainer, KFx
TOP
Improving access to BBV testing and treatment
Kim Michelle, CRI Service Manager, CRI, Stockton-on-Tees
TOP
Staying safe: injectors who avoid hepatitis C
Magdalena Harris, Research Fellow, Centre for Research on Drugs and Health Behaviour, London School of Hygiene and Tropical Medicine
TOP
National hep C action plan prevention initiatives in Greater Glasgow and Clyde
Jennifer Kelly, Addiction Pharmacist, Glasgow Addiction Service
From fix to foil. The Dutch experience in promoting transition away from injecting drug use, 1991 - 2010. A case study, analysis and lessons learned
and
Promoting transition to smoking in the UK: panel discussion
John Peter Kools, Consultant on Drug Use, HIV and Harm Reduction, Amsterdam, Netherlands
TOP
The R.I.O.T.T. & what it's done for us
Melissa Lee, Co-chair of Recovery On/Off Alcohol & Drugs (R.O.A.D), Brighton
Safer injecting, bacterial, viral infections. A new kind of workshop
Tony Lee, Volunteer Service User Advocate / Peer Supporter / Educator, R.E.P.S (Recovery, Empowerment, Peer Support), Fleetwood
Tales from the robber's dog - The ballad of the two Charlies
Michael Linnell, Director of Communications, Lifeline, Manchester
Pharmacological treatment possibilities for older cocaine users
Judith Livingston, Doctor, University College Hospital, London
TOP
National hep C action plan prevention initiatives in Greater Glasgow and Clyde
Mary Clare Madden, Addiction Pharmacist, Glasgow Addiction Service
Groin injecting in Bristol - has anything changed in 5 years?
John Maliphant, Harm Reduction Coordinator, Bristol Drugs Project
The injecting of human growth hormone (HGH) as a performance enhancing drug
Jim McVeigh, Head of Substance Use, Centre for Public Health, Liverpool John Moores University
Improving access to BBV testing and treatment
Kim Michelle, CRI Service Manager, CRI, Stockton-on-Tees
TOP
Heroin prescribing: the story behind the perfect script
and
Route transition - ethical challenges and future opportunities
Erin O'Mara, Editor, Black Poppy
TOP
Hepatitis C prevalence and incidence among injecting drug users attending injecting equipment provision services in Scotland
Norah Palmateer, Epidemiologist, Health Protection Scotland, Glasgow
Blue lights in public conveniences: The amplification of injected-related risk behaviour (and the challenge for harm reduction)
Stephen Parkin, Research Fellow in Public Health Sociology, Drug and Alcohol Research Unit, School of Social Science and Social Work, University of Plymouth
Promoting transition to smoking in the UK: panel discussion
Rachael Pizzey, Turning Point, Somerset
TOP
Neck injecting: a new phenomenon?
and
Neck injecting risks and harm reduction
David Robertson, Specialist Nurse in Substance Misuse, NHS Islington, London
Inverness naloxone programme
Lisa Ross, Clinical Harm Reduction Nurse Specialist, NHS Highland Harm Reduction Service, Scotland
TOP
Groin injecting in Bristol - has anything changed in 5 years?
Paul Sargent, Harm Reduction Coordinator, Bristol Drugs Project
Harm reduction advice based on laboratory analysis of crack cocaine adulteration
and
Groin injecting in Bristol - has anything changed in 5 years?
Jenny Scott, Senior Lecturer in Pharmacy Practice, Department of Pharmacy and Pharmacology, University of Bath
Ultrasound and femoral injecting
Richard Senbanjo, Clinical Director, KCA UK
Pharmacological treatment possibilities for older cocaine users
Adam Showman, Post-Graduate Student, King's College, London
Route transition - ethical challenges and future opportunities
and
Promoting transition to smoking in the UK: panel discussion
Matthew Southwell, The Gold Standard Team, Bath
TOP
Harm reduction suites
Alyson Taylor, Service Development and Improvement Manager, Leicester DAAT
BBV prevention for young people: The Waiting Room'. A BBV prevention film and education toolkit for use with vulnerableyoung people
Colin Tyrie, Senior Public Health Development Advisor (Substance Misuse), Manchester Public Health Development Service, NHS Manchester
TOP
Can antiviral therapy for HCV be a prevention tool for active IDUs? A modelling analysis
Peter Vickerman, Senior Lecturer of Mathematical Epidemiology, London School of Hygiene and Tropical Medicine
TOP
Neck injecting risks and harm reduction
Louise Wilkins, Drug Worker, The Health Shop, Nottingham
Do you share? - Looking beyond the 'sharing' question
Helen Wilks, Trainer, Torbay
TOP
Do low dead space syringes prevent injection-related HIV epidemics among IDUs?
William A. Zule Sr. Research Public Health Analyst, RTI International, Research Triangle Park, USA
TOP
|
